Carlos Nueno - 27 Feb 2026 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
President, International
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
27 Feb 2026
Net transactions value
-$103,184
Form type
4
Filing time
03 Mar 2026, 16:10:50 UTC
Previous filing
03 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Nueno Carlos President, International C/O TELADOC HEALTH, INC.,, 155 E 44TH ST, SUITE 1700, NEW YORK /s/ Adam C. Vandervoort, Attorney-in-Fact 03 Mar 2026 0002037711

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +3,101 +11% 30,276 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +4,556 +15% 34,832 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +34,867 +100% 69,699 27 Feb 2026 Direct F1
transaction TDOC Common Stock Options Exercise +1,061 +1.5% 70,760 27 Feb 2026 Direct F2
transaction TDOC Common Stock Sale $103,184 -20,165 -28% $5.12 50,595 02 Mar 2026 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -3,101 -100% $0.000000 0 27 Feb 2026 Common Stock 3,101 Direct F1, F4
transaction TDOC Restricted Stock Units Options Exercise $0 -4,556 -20% $0.000000 18,226 27 Feb 2026 Common Stock 4,556 Direct F1, F5
transaction TDOC Restricted Stock Units Options Exercise $0 -34,867 -33% $0.000000 69,735 27 Feb 2026 Common Stock 34,867 Direct F1, F6
transaction TDOC Performance Stock Units Options Exercise $0 -1,061 -100% $0.000000 0 27 Feb 2026 Common Stock 1,061 Direct F2, F7
transaction TDOC Restricted Stock Units Award $0 +173,010 $0.000000 173,010 01 Mar 2026 Common Stock 173,010 Direct F8, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
F3 Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
F4 On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5 On March 19, 2024, the reporting person was granted 54,675 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F6 On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F7 On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F8 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F9 One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.